CRVL Q4 2026 Earnings Call Summary | Stock Taper
Logo
CRVL

CRVL — CorVel Corporation

NASDAQ


Q4 2026 Earnings Call Summary

May 20, 2026

Summary of CorVel (CRVL) Q4 2026 Earnings Call

1. Key Financial Results and Metrics

  • Q4 Revenue: $249 million, up 7% from $232 million in Q4 2025.
  • Earnings Per Share (EPS): $0.61, an increase from $0.51 year-over-year.
  • Fiscal Year 2026 Revenue: $959 million, a 7% increase from $896 million in FY 2025.
  • Fiscal Year EPS: $2.14, up 17% from $1.83 in FY 2025.
  • Net Income: $110 million for FY 2026, a 14% increase from $95 million in FY 2025.
  • Operating Margin: Improved to 15%, up 1.4% from FY 2025.
  • Free Cash Flow: $66 million, a $7 million increase from FY 2025.
  • Cash Balance: $233 million at fiscal year-end.
  • Share Repurchase: 872,744 shares repurchased in FY 2026 for $56 million; total repurchased shares since inception: 115.3 million (69% of total shares outstanding).

2. Strategic Updates and Business Highlights

  • Network Solutions: Strong performance with double-digit revenue and profit growth, driven by new large payer engagements and elevated post-payment recoveries.
  • Patient Management: Low single-digit revenue growth, focusing on operational efficiency and service quality improvements.
  • New Bookings: Increased by 56% year-over-year, with RFP activity up 20%, indicating a robust pipeline.
  • Technological Investments: Continued focus on AI and automation to enhance service delivery and operational efficiency.
  • Market Trends: Shift towards proactive payment accuracy and cost management models, with CorVel's CERIS platform positioned to capitalize on this trend.

3. Forward Guidance and Outlook

  • Anticipated ongoing revenue and profit growth from new multiyear partnerships with top national payers.
  • Expected productivity gains through automation and AI enhancements, which should improve operating leverage and reduce manual processes.
  • Continued focus on expanding prepaid solutions to create a more predictable revenue model.

4. Bad News, Challenges, or Points of Concern

  • Increased Effective Tax Rate: The rise in the effective tax rate impacted earnings growth, although some effects were mitigated by business growth.
  • Personnel Levels: Increased personnel to support service delivery may lead to higher costs until automation and AI are fully implemented.
  • Market Pressures: The healthcare environment is facing rising claims severity and complexity, which could challenge operational efficiency and cost management.

5. Notable Q&A Insights

  • No questions were raised during the call, indicating either a lack of immediate concerns from analysts or a strong confidence in the reported results and strategic direction.

Overall, CorVel demonstrated solid financial performance and strategic positioning in a challenging healthcare environment, with a focus on technology and proactive solutions to drive future growth.